Premium
Adrenergic beta 2 ‐selective blocker in isoprenaline‐enhanced essential tremor
Author(s) -
Teräväinen Heikki,
Huttunen Juha
Publication year - 1987
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.870020204
Subject(s) - isoprenaline , propranolol , antagonist , essential tremor , adrenergic , beta (programming language) , adrenergic receptor , chemistry , pharmacology , beta blocker , medicine , endocrinology , receptor , heart failure , stimulation , computer science , physical medicine and rehabilitation , programming language
A beta 2 ‐selective adrenergic‐receptor‐blocking drug, ICI 118.551,150 mg/day, prevented almost as effectively as the nonselective antagonist propranolol, 240 mg/day, the isoprenaline enhancement of essential tremor amplitude.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom